Barely Significant
← all excerpts

Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies.

J Immunother Cancer · 2023 · PMC10603328 · PMID 37865395

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

did not reach statistical significancep value=0.10so close (0.05 < p ≤ 0.1)
Similarly, higher proportions of responders were observed in both the immune-intermediate and immune-rich classes in patients treated with IPI+PD-1 (immune-rich: 77% vs 23%, immune-intermediate: 68% vs 32%, and immune-scarce: 48% vs 52%; figure 5E ), though this association did not reach statistical significance (p value=0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.